Wellington Management Group LLP Reduces Holdings in Henry Schein, Inc. (NASDAQ:HSIC)

Wellington Management Group LLP lessened its holdings in Henry Schein, Inc. (NASDAQ:HSIC) by 11.7% during the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 6,127 shares of the company’s stock after selling 810 shares during the period. Wellington Management Group LLP’s holdings in Henry Schein were worth $447,000 at the end of the most recent reporting period.

Several other large investors have also modified their holdings of the business. Blue Trust Inc. raised its position in shares of Henry Schein by 104.2% during the 2nd quarter. Blue Trust Inc. now owns 931 shares of the company’s stock worth $60,000 after purchasing an additional 475 shares during the last quarter. Raymond James & Associates raised its holdings in shares of Henry Schein by 2.0% in the second quarter. Raymond James & Associates now owns 292,166 shares of the company’s stock worth $18,728,000 after acquiring an additional 5,763 shares during the last quarter. Fifth Third Bancorp lifted its position in shares of Henry Schein by 41.8% in the second quarter. Fifth Third Bancorp now owns 2,793 shares of the company’s stock valued at $179,000 after acquiring an additional 824 shares in the last quarter. Tempus Wealth Planning LLC boosted its stake in shares of Henry Schein by 6.0% during the second quarter. Tempus Wealth Planning LLC now owns 4,607 shares of the company’s stock valued at $295,000 after acquiring an additional 260 shares during the last quarter. Finally, Summit Securities Group LLC purchased a new stake in Henry Schein during the 2nd quarter worth about $31,000. 96.62% of the stock is currently owned by institutional investors and hedge funds.

Analysts Set New Price Targets

HSIC has been the topic of several analyst reports. Mizuho began coverage on shares of Henry Schein in a research note on Wednesday, December 4th. They set a “neutral” rating and a $75.00 price target on the stock. Barrington Research restated an “outperform” rating and set a $82.00 target price on shares of Henry Schein in a research report on Wednesday, November 6th. Evercore ISI boosted their price target on Henry Schein from $70.00 to $74.00 and gave the company an “in-line” rating in a report on Tuesday, October 8th. Finally, StockNews.com upgraded Henry Schein from a “sell” rating to a “hold” rating in a report on Thursday, November 7th. Seven investment analysts have rated the stock with a hold rating, four have assigned a buy rating and one has given a strong buy rating to the stock. According to MarketBeat.com, Henry Schein presently has an average rating of “Moderate Buy” and a consensus price target of $78.89.

Insider Buying and Selling at Henry Schein

In other Henry Schein news, COO Michael S. Ettinger sold 12,240 shares of the firm’s stock in a transaction dated Monday, November 18th. The stock was sold at an average price of $75.00, for a total value of $918,000.00. Following the transaction, the chief operating officer now directly owns 87,706 shares of the company’s stock, valued at $6,577,950. This trade represents a 12.25 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. 1.14% of the stock is currently owned by corporate insiders.

Henry Schein Trading Up 1.3 %

Shares of HSIC opened at $69.82 on Friday. Henry Schein, Inc. has a twelve month low of $63.67 and a twelve month high of $82.63. The firm has a market capitalization of $8.71 billion, a P/E ratio of 28.73, a price-to-earnings-growth ratio of 2.31 and a beta of 0.87. The company has a current ratio of 1.42, a quick ratio of 0.82 and a debt-to-equity ratio of 0.46. The stock’s fifty day simple moving average is $72.39 and its 200 day simple moving average is $70.13.

Henry Schein (NASDAQ:HSIC) last released its quarterly earnings data on Tuesday, November 5th. The company reported $1.22 earnings per share for the quarter, beating the consensus estimate of $1.17 by $0.05. The business had revenue of $3.17 billion for the quarter, compared to analyst estimates of $3.24 billion. Henry Schein had a return on equity of 12.90% and a net margin of 2.51%. The company’s revenue was up .4% compared to the same quarter last year. During the same period in the previous year, the company posted $1.32 EPS. On average, equities research analysts forecast that Henry Schein, Inc. will post 4.78 earnings per share for the current year.

Henry Schein Profile

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.